‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s – National
Health Canada has approved a second drug that can slow the progression of Alzheimer’s disease. Donanemab, sold by…
Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one
Less than 20% of people who showed interest in taking new medications for Alzheimer’s disease went on to…